📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: VaxGen

1.1 - Company Overview

VaxGen Logo

VaxGen

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical products in the United States.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to VaxGen

Tectonic Therapeutics Logo

Tectonic Therapeutics

HQ: United States Website
  • Description: Provider of GPCR-targeted biologic drug discovery and development via its GEODe platform, with clinical programs including TX45, a therapeutic protein in Phase 1B trials for Group 2 Pulmonary Hypertension in heart failure with preserved ejection fraction, and an Fc-relaxin fusion targeting the RXFP1 receptor.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tectonic Therapeutics company profile →
Caelum Biosciences Logo

Caelum Biosciences

HQ: United States Website
  • Description: Provider of clinical-stage biotechnology developing treatments for rare and life-threatening diseases, with lead asset CAEL-101 (mAb 11-1F4), a novel antibody licensed from Columbia University in January 2017 for the treatment of amyloid light chain (AL) amyloidosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Caelum Biosciences company profile →
NextPoint Therapeutics Logo

NextPoint Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage therapeutics to treat cancer, including NPX887 targeting HHLA2 and NPX267 targeting KIR3DL3 to reactivate exhausted T and NK cells in HHLA2+ solid tumors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NextPoint Therapeutics company profile →
Kairos Therapeutics Logo

Kairos Therapeutics

HQ: Canada Website
  • Description: Provider of a proprietary next-generation antibody-drug conjugate platform as a biopharmaceutical company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kairos Therapeutics company profile →
Replimune Logo

Replimune

HQ: United States Website
  • Description: Provider of next-generation oncolytic immunotherapies for cancer, developing proprietary products that enhance direct anti-tumor effects of selective virus replication and boost immune responses to tumor antigens. Products include RP1 (HSV-1 strain with immune-activating transgenes), RP2 (anti-CTLA-4 antibody targeting immunologically silent tumors to enhance tumor killing and immune response), and RP3 (CD40L and 4-1BBL ligands).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Replimune company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for VaxGen

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to VaxGen

2.2 - Growth funds investing in similar companies to VaxGen

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for VaxGen

4.2 - Public trading comparable groups for VaxGen

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to VaxGen

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About VaxGen

What does VaxGen do?

VaxGen is a provider of biopharmaceutical products in the United States.

Who are VaxGen's competitors?

VaxGen's competitors and similar companies include Tectonic Therapeutics, Caelum Biosciences, NextPoint Therapeutics, Kairos Therapeutics, and Replimune.

Where is VaxGen headquartered?

VaxGen is headquartered in United States.

How many employees does VaxGen have?

VaxGen has 1,000 employees 🔒.

When was VaxGen founded?

VaxGen was founded in 2010 🔒.

What sector and industry vertical is VaxGen in?

VaxGen is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for VaxGen

Who are the top strategic acquirers in VaxGen's sector and industry

Top strategic M&A buyers and acquirers in VaxGen's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for VaxGen?

Top strategic M&A buyers groups and sectors for VaxGen include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in VaxGen's sector and industry vertical

Which are the top PE firms investing in VaxGen's sector and industry vertical?

Top PE firms investing in VaxGen's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in VaxGen's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in VaxGen's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in VaxGen's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to VaxGen include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in VaxGen's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for VaxGen?

The key public trading comparables and valuation benchmarks for VaxGen include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for VaxGen for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for VaxGen with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in VaxGen's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for VaxGen with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in VaxGen's' sector and industry vertical?

Access recent funding rounds and capital raises in VaxGen's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for VaxGen